These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31015308)

  • 1. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.
    Sima LE; Yakubov B; Zhang S; Condello S; Grigorescu AA; Nwani NG; Chen L; Schiltz GE; Arvanitis C; Zhang ZY; Matei D
    Mol Cancer Ther; 2019 Jun; 18(6):1057-1068. PubMed ID: 31015308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction.
    Yakubov B; Chen L; Belkin AM; Zhang S; Chelladurai B; Zhang ZY; Matei D
    PLoS One; 2014; 9(2):e89285. PubMed ID: 24586660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
    Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
    Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
    Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
    J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
    Khanna M; Chelladurai B; Gavini A; Li L; Shao M; Courtney D; Turchi JJ; Matei D; Meroueh S
    Mol Cancer Ther; 2011 Apr; 10(4):626-36. PubMed ID: 21330459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
    Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
    FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
    Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
    Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.
    Akimov SS; Krylov D; Fleischman LF; Belkin AM
    J Cell Biol; 2000 Feb; 148(4):825-38. PubMed ID: 10684262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
    Forsprecher J; Wang Z; Nelea V; Kaartinen MT
    Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
    Condello S; Cao L; Matei D
    FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
    Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
    Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase 2 has higher affinity for relaxed than for stretched fibronectin fibers.
    Selcuk K; Leitner A; Braun L; Le Blanc F; Pacak P; Pot S; Vogel V
    Matrix Biol; 2024 Jan; 125():113-132. PubMed ID: 38135164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the interaction between transglutaminase 2 and fibronectin.
    Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
    Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex.
    Wang Z; Telci D; Griffin M
    Exp Cell Res; 2011 Feb; 317(3):367-81. PubMed ID: 21036168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
    Herman JF; Mangala LS; Mehta K
    Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.
    Telci D; Wang Z; Li X; Verderio EA; Humphries MJ; Baccarini M; Basaga H; Griffin M
    J Biol Chem; 2008 Jul; 283(30):20937-47. PubMed ID: 18499669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2).
    Valdivia A; Vagadia PP; Guo G; O'Brien E; Matei D; Schiltz GE
    J Med Chem; 2023 Jul; 66(14):9445-9465. PubMed ID: 37449845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
    Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
    Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.